Gender differences in adiponectin modulation of cardiac remodeling in mice deficient in endothelial nitric oxide synthase

Journal of Cellular Biochemistry

Volumn 113, Issue 10, 2012, Pages 3276-3287

  Durand, Jorge L ^a,c   Nawrocki, Andrea R ^a,d   Scherer, Philipp E ^a,b   Jelicks, Linda A ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c Iris Global Clinical Trials Solutions   (United States)

^d MERCK RESEARCH LABORATORIES   (United States)

Author keywords

Adiponectin; cardiac remodeling; eNOS; hypertension; left ventricular hypertrophy; MRI

Indexed keywords

ADIPONECTIN; ENDOTHELIAL NITRIC OXIDE SYNTHASE;

ANIMAL EXPERIMENT; ANIMAL FOOD; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARDIAC IMAGING; ENZYME DEFICIENCY; FEMALE; HEART FUNCTION; HEART LEFT VENTRICLE; HEART LEFT VENTRICLE HYPERTROPHY; HEART PROTECTION; HEART VENTRICLE REMODELING; HYPOTHESIS; LIPID DIET; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEX DIFFERENCE; STATISTICAL SIGNIFICANCE;

ADIPONECTIN; ANIMALS; BLOOD GLUCOSE; BLOOD PRESSURE DETERMINATION; BODY WEIGHT; CROSSES, GENETIC; DIET, HIGH-FAT; FEMALE; GENOTYPE; HEART FUNCTION TESTS; HEART VENTRICLES; HYPERTENSION; MAGNETIC RESONANCE IMAGING; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NITRIC OXIDE SYNTHASE TYPE III; SEX FACTORS; TIME FACTORS; VENTRICULAR REMODELING;

EID: 84865006433     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.24206     Document Type: Article

References (50)

1. Ai M, Otokozawa S, Asztalos BF, White CC, Cupples LA, Nakajima K, Lamon-Fava S, Wilson PW, Matsuzawa Y, Schaefer EJ,. 2011. Adiponectin: An independent risk factor for coronary heart disease in men in the Framingham offspring study. Atherosclerosis 217: 543-548.
2. Amengual-Cladera E, Llado I, Gianotti M, Proenza AM,. 2012. Sex differences in the effect of high-fat diet feeding on rat white adipose tissue mitochondrial function and insulin sensitivity. Metabolism. in press, http://dx.doi.org/10.1016/j.metabol.2011.12.016.
3. Berg HA, Scherer PE,. 2005. Adipose tissue, inflammation, and cardiovascular disease. Circ Res 96: 939-949.
4. Brakenhielm E, Veitonmaki N, Cao R, Kihara S, Matsuzawa Y, Zhivotovsky B, Funahashi T, Cao Y,. 2004. Adiponectin-induced antiangiogenesis and antitumor activity involve caspase-mediated endothelial cell apoptosis. Proc Natl Acad Sci USA 101: 2476-2481.
5. Burlew BS, Weber KT,. 2002. Cardiac fibrosis as a cause of diastolic dysfunction. Herz 27: 92-98.
6. Buys ES, Raher MJ, Blake SL, Neilan TG, Graveline AR, Passeri JJ, Llano M, Perez-Sanz TM, Ichinose F, Janssens S, Zapol WM, Picard MH, Bloch KD, Scherrer-Crosbie M,. 2007. Cardiomyocyte-restricted restoration of nitric oxide synthase 3 attenuates left ventricular remodeling after chronic pressure overload. Am J Physiol Heart Circ Physiol 293: H620-H627.
7. Cao Y, Tao L, Yuan Y, Jiao X, Lau WB, Wang Y, Christopher T, Lopez B, Chan L, Goldstein B, Ma XL,. 2009. Endothelial dysfunction in adiponectin deficiency and its mechanisms involved. J Mol Cell Cardiol 46: 413-419.
8. Cheng KK, Lam KS, Wang Y, Huang Y, Carling D, Wu D, Wong C, Xu A,. 2007. Adiponectin-induced endothelial nitric oxide synthase activation and nitric oxide production are mediated by APPL1 in endothelial cells. Diabetes 56: 1387-1394.
9. Combs TP, Pajvani UB, Berg AH, Lin Y, Jelicks LA, Laplante M, Nawrocki AR, Rajala MW, Parlow AF, Cheeseboro L, Ding YY, Russell RG, Lindemann D, Hartley A, Baker GR, Obici S, Deshaies Y, Ludgate M, Rossetti L, Scherer PE,. 2004. A transgenic mouse with a deletion in the collagenous domain of adiponectin displays elevated circulating adiponectin and improved insulin sensitivity. Endocrinology 145: 367-383.
10. Durand JL,. 2008. Cardiac Remodeling in eNOS deficient mice modulated by adiponectin levels. Bronx, NY: Albert Einstein College of Medicine. pp 28-31.
11. Durand JL, Tang B, Gutstein DE, Petkova S, Teixeira MM, Tanowitz HB, Jelicks LA,. 2006. Dyskinesis in Chagasic myocardium: Centerline analysis of wall motion using cardiac-gated magnetic resonance images of mice. Magn Reson Imaging 24: 1051-1057.
12. El Akoum S, Lamontagne V, Cloutier I, Tanguay JF,. 2011. Nature of fatty acids in high fat diets differentially delineates obesity-linked metabolic syndrome components in male and female C57BL/6J mice. Diabetol Metab Syndr 3: 34.
13. Flaherty MP, Brown M, Grupp IL, Schultz JE, Murphree SS, Jones WK,. 2007. eNOS deficient mice develop progressive cardiac hypertrophy with altered cytokine and calcium handling protein expression. Cardiovasc Toxicol 7: 165-177.
14. George J, Patal S, Wexler D, Sharabi Y, Peleg E, Kamari Y, Grossman E, Sheps D, Keren G, Roth A,. 2006. Circulating adiponectin concentrations in patients with congestive heart failure. Heart 92: 1420-1424.
15. Holland WL, Miller RA, Wang ZV, Sun K, Barth BM, Bui HH, Davis KE, Bikman BT, Halberg N, Rutkowski JM, Wade MR, Tenorio VM, Kuo MS, Brozinick JT, Zhang BB, Birnbaum MJ, Summers SA, Scherer PE,. 2011. Receptor-mediated activation of ceramidase activity initiates the pleiotropic actions of adiponectin. Nat Med 17: 55-63.
16. Hopkins TA, Ouchi N, Shibata R, Walsh K,. 2007. Adiponectin actions in the cardiovascular system. Cardiovasc Res 74: 11-18.
17. Huang A, Sun D, Shesely EG, Levee EM, Koller A, Kaley G,. 2002. Neuronal NOS-dependent dilation to flow in coronary arteries of male eNOS-KO mice. Am J Physiol Heart Circ Physiol 282: H429-H436.
18. Ichinose F, Bloch KD, Wu JC, Hataishi R, Aretz HT, Picard MH, Scherrer-Crosbie M,. 2004. Pressure overload-induced LV hypertrophy and dysfunction in mice are exacerbated by congenital NOS3 deficiency. Am J Physiol Heart Circ Physiol 286: H1070-H1075.
19. Iwashima Y, Katsuya T, Ishikawa K, Ouchi N, Ohishi M, Sugimoto K, Fu Y, Motone M, Yamamoto K, Matsuo A, Ohashi K, Kihara S, Funahashi T, Rakugi H, Matsuzawa Y, Ogihara T,. 2004. Hypoadiponectinemia is an independent risk factor for hypertension. Hypertension 43: 1318-1323.
20. Janssens S, Pokreisz P, Schoonjans L, Pellens M, Vermeersch P, Tjwa M, Jans P, Scherrer-Crosbie M, Picard MH, Szelid Z, Gillijns H, Van de Werf F, Collen D, Bloch KD,. 2004. Cardiomyocyte-specific overexpression of nitric oxide synthase 3 improves left ventricular performance and reduces compensatory hypertrophy after myocardial infarction. Circ Res 94: 1256-1262.
21. Kim JY, van de Wall E, Laplante M, Azzara A, Trujillo ME, Hofmann SM, Schraw T, Durand JL, Li H, Li G, Jelicks LA, Mehler MF, Hui DY, Deshaies Y, Shulman GI, Schwartz GJ, Scherer PE,. 2007. Obesity-associated improvements in metabolic profile through expansion of adipose tissue. J Clin Invest 117: 2621-2637.
22. Kizer JR, Barzilay JI, Kuller LH, Gottdiener JS,. 2008. Adiponectin and risk of coronary heart disease in older men and women. J Clin Endocrinol Metab 93: 3357-3364.
23. Koren MJ, Ulin RJ, Koren AT, Laragh JH, Devereux RB,. 2002. Left ventricular mass change during treatment and outcome in patients with essential hypertension. Am J Hypertens 15: 1021-1028.
24. Landskroner-Eiger S, Qian B, Muise ES, Nawrocki AR, Berger JP, Fine EJ, Koba W, Deng Y, Pollard JW, Scherer PE,. 2009. Proangiogenic contribution of adiponectin toward mammary tumor growth in vivo. Clin Cancer Res 15: 3265-3276.
25. Mahadev K, Wu X, Donnelly S, Ouedraogo R, Eckhart AD, Goldstein BJ,. 2008. Adiponectin inhibits vascular endothelial growth factor-induced migration of human coronary artery endothelial cells. Cardiovasc Res 78: 376-384.
26. Matsumoto T, Mugishima H,. 2006. Signal transduction via vascular endothelial growth factor (VEGF) receptors and their roles in atherogenesis. J Atheroscler Thromb 13: 130-135.
27. Mungrue IN, Husain M, Stewart DJ,. 2002. The role of NOS in heart failure: Lessons from murine genetic models. Heart Failure Rev 7: 407-422.
28. Munzel T, Sinning C, Post F, Warnholtz A, Schulz E,. 2008. Pathophysiology, diagnosis and prognostic implications of endothelial dysfunction. Ann Med 40: 180-196.
29. Nakata S, Tsutsui M, Shimokawa H, Suda O, Morishita T, Shibata K, Yatera Y, Sabanai K, Tanimoto A, Nagasaki M, Tasaki H, Sasaguri Y, Nakashima Y, Otsuji Y, Yanagihara N,. 2008. Spontaneous myocardial infarction in mice lacking all nitric oxide synthase isoforms. Circulation 117: 2211-2223.
30. Nawrocki AR, Rajala MW, Tomas E, Pajvani UB, Saha AK, Trumbauer ME, Pang Z, Chen AS, Ruderman NB, Chen H, Rossetti L, Scherer PE,. 2006. Mice lacking adiponectin show decreased hepatic insulin sensitivity and reduced responsiveness to peroxisome proliferator-activated receptor gamma agonists. J Biol Chem 281: 2654-2660.
31. Ouchi N, Kobayashi H, Kihara S, Kumada M, Sato K, Inoue T, Funahashi T, Walsh K,. 2004. Adiponectin stimulates angiogenesis by promoting cross-talk between AMP-activated protein kinase and Akt signaling in endothelial cells. J Biol Chem 279: 1304-1309.
32. Pischon T, Hu FB, Girman CJ, Rifai N, Manson JE, Rexrode KM, Rimm EB,. 2011. Plasma total and high molecular weight adiponectin levels and risk of coronary heart disease in women. Atherosclerosis 219: 322-329.
33. Prior BM, Yang HT, Terjung RL,. 2004. What makes vessels grow with exercise training? J Appl Physiol 97: 1119-1128.
34. Schautz B, Later W, Heller M, Peters A, Muller MJ, Bosy-Westphal A,. 2012. Impact of age on leptin and adiponectin independent of adiposity. Br J Nutr in press, Available on CJO 2012 doi:10.1017/S0007114511005605.
35. Scherer PE, Williams S, Fogliano M, Baldini G, Lodish HF,. 1995. A novel serum protein similar to C1q, produced exclusively in adipocytes. J Biol Chem 270: 26746-26749.
36. Schmid PM, Resch M, Steege A, Fredersdorf-Hahn S, Stoelcker B, Birner C, Schach C, Buechler C, Riegger GA, Luchner A, Endemann DH,. 2011. Globular and full-length adiponectin induce NO-dependent vasodilation in resistance arteries of Zucker lean but not Zucker diabetic fatty rats. Am J Hypertens 24: 270-277.
37. Shibata R, Ouchi N, Kihara S, Sato K, Funahashi T, Walsh K,. 2004. Adiponectin stimulates angiogenesis in response to tissue ischemia through stimulation of amp-activated protein kinase signaling. J Biol Chem 279: 28670-28674.
38. Shibata R, Sato K, Pimentel DR, Takemura Y, Kihara S, Ohashi K, Funahashi T, Ouchi N, Walsh K,. 2005. Adiponectin protects against myocardial ischemia-reperfusion injury through AMPK- and COX-2-dependent mechanisms. Nat Med 11: 1096-1103.
39. Shibata R, Izumiya Y, Sato K, Papanicolaou K, Kihara S, Colucci WS, Sam F, Ouchi N, Walsh K,. 2007. Adiponectin protects against the development of systolic dysfunction following myocardial infarction. J Mol Cell Cardiol 42: 1065-1074.
40. Silha JV, Krsek M, Sucharda P, Murphy LJ,. 2005. Angiogenic factors are elevated in overweight and obese individuals. Int J Obes (Lond) 29: 1308-1314.
41. Siri FM, Jelicks LA, Leinwand LA, Gardin JM,. 1997. Gated magnetic resonance imaging of normal and hypertrophied murine hearts. Am J Physiol 272: H2394-H2402.
42. Stein DT, Babcock EE, Szczepaniak LS,. 1998. Monitoring of body composition changes during the development of genetic obesity using 1H MRS. Proc Int Soc Mag Res Med 6: 1839.
43. Sumeray MS, Rees DD, Yellon DM,. 2000. Infarct size and nitric oxide synthase in murine myocardium. J Mol Cell Cardiol 32: 35-42.
44. Tirziu D, Chorianopoulos E, Moodie KL, Palac RT, Zhuang ZW, Tjwa M, Roncal C, Eriksson U, Fu Q, Elfenbein A, Hall AE, Carmeliet P, Moons L, Simons M,. 2007. Myocardial hypertrophy in the absence of external stimuli is induced by angiogenesis in mice. J Clin Invest 117: 3188-3197.
45. van Nieuw Amerongen GP, Koolwijk P, Versteilen A, van Hinsbergh VW,. 2003. Involvement of RhoA/Rho kinase signaling in VEGF-induced endothelial cell migration and angiogenesis in vitro. Arterioscler Thromb Vasc Biol 23: 211-217.
46. Vecoli C, Cao J, Neglia D, Inoue K, Sodhi K, Vanella L, Gabrielson KK, Bedja D, Paolocci N, L'Abbate A, Abraham NG,. 2011. Apolipoprotein A-I mimetic peptide L-4F prevents myocardial and coronary dysfunction in diabetic mice. J Cell Biochem 112: 2616-2626.
47. Verdecchia P, Angeli F, Gattobigio R, Sardone M, Pede S, Reboldi GP,. 2006. Regression of left ventricular hypertrophy and prevention of stroke in hypertensive subjects. Am J Hypertens 19: 493-499.
48. Wang ZV, Scherer PE,. 2008. Adiponectin, cardiovascular function, and hypertension. Hypertension 51: 8-14.
49. Wong WT, Tian XY, Xu A, Yu J, Lau CW, Hoo RL, Wang Y, Lee VW, Lam KS, Vanhoutte PM, Huang Y,. 2011. Adiponectin is required for PPARgamma-mediated improvement of endothelial function in diabetic mice. Cell Metab 14: 104-115.
50. Xin Y, Song X, Xue H, Liu Z, Wang X, Wang H, Sun K, Bai Y, Liu J, Hui R,. 2009. A common variant of the eNOS gene (E298D) is an independent risk factor for left ventricular hypertrophy in human essential hypertension. Clin Sci (Lond) 117: 67-73.